Linagliptin is a DPP-4 inhibitor for treatment of type II diabetes.
Linagliptin belongs to a class of drugs called DPP-4 inhibitors. DPP-4 inhibitors work by increasing hormones that stimulate your pancreas to produce more insulin and stimulate your liver to produce less glucose.In other words, Linagliptin, along with diet and exercise, can help your body produce more insulin and less sugar. Managing your sugar can mean a lower A1C - and thats an important goal for anyone with type 2 diabetes.